Trial intelligence / Profile preview

Oral esketamine + midazolam for preoperative anxiety in children

ChiCTR2400080633Phase 4Not yet recruiting

Sponsor
Xi'an International Medical Center Hospital
Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine and midazolam in separation anxiety disorder (SAD), sponsored by Xi'an International Medical Center Hospital. Planned start Mar 2024; status: not yet recruiting.

02

Drugs

esketaminemidazolam
03

Conditions

separation anxiety disorder (SAD)

Beyond the preview

Go deeper on ChiCTR2400080633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400080633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call